Biblio
Continuous Elotuzumab, Pomalidomide and Dexamethasone Maintenance Following Second Autologous Transplant for Multiple Myeloma: Results of a Prospective, Phase 2 Multicenter Trial. Transplant Cell Ther. 2023.
. The Impact of CD34 Cell Collection Yields for Autologous Transplant on Survival Outcomes in Multiple Myeloma. Clin Lymphoma Myeloma Leuk. 2023.
. Lenalidomide and Dexamethasone in Transplant-Ineligible Patients with Myeloma. N Engl J Med. 2014;371(10):906-917.
Post Salvage Therapy Autologous Transplant for Relapsed Myeloma, Ongoing Relevance within Modern Treatment Paradigms?. Clin Lymphoma Myeloma Leuk. 2022.